The two drugs are not interchangeable nor dose equivalents.
Mycophenolate mofetil (Cellcept) is a semi synthetic prodrug that is rapidly hydrolyzed in vivo to form the active metabolite, mycophenolic acid (MPA).
Mycophenolate sodium (Myfortic) is an enteric-coated formulation which allows delayed release of MPA into the small intestine.
Myfortic causes less diarrhea, indigestion, and abdominal compared to CellCept.
REFERENCES:
Manger B, Hiepe F, Schneider M, et al. Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study. Clin Exp Gastroenterol. 2015;8:205-213. Published 2015 Jul 21. doi:10.2147/CEG.S81922
It is not clearly understood why patients with pulmonary hypertension (PH) develop pericardial effusions. However,…
Serum Creatinine can be a deceptive surrogate during an acute kidney injury. It may lag…
Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases (i.e SLE, Juvenile idiopathic…
After creation of a percutaneous tracheotomy site for prolonged ventilation, one of the immediate complications…
Two systematic reviews have assessed the diagnostic accuracy of elements of the medical history, physical…
SYMPTOMS THAT RULE OUT (Lowest -LR): The absence of pain of sudden onset substantively decreases…
This website uses cookies.